Transaction · 0001104659-26-106831

Patel Dinesh V Ph D

PATEL DINESH V PH D, PRES, reported an open-market or private sale at Protagonist Therapeutics, Inc involving 54174.000000 shares for an estimated $7902361.38. Reported holdings after the transaction were 522968.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SPRES
PTGXProtagonist Therapeutics, Inc
Trade date
Sep 08, 2026
Filing date
Sep 11, 2026
View on SEC Insider profile
Estimated value-$7.90MShares × reported price
Shares traded54.1k$145.87 per share
Holdings after522kDirect
% of reported position traded9.39%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 577,142 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

PTGX price since this filing

Daily closing prices, with the filing date and available return windows
PTGX · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -1.6%1w ago +4.4%1d ago +4.4%
Returns since7d -3.5%30d -3.0%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001104659-26-106831
Common Stock
Transaction date
Sep 08, 2026
Filed Sep 11, 2026, 01:17 AM · 3d delay
Shares
54,174 sh
$145.87 per share
Estimated value
-$7.90M
Computed from shares × price
Holdings after
522,968 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Sale 10b5-1 Detected
Filing-only score

-4 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President and CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The transactions set forth on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on January 30, 2026. The 10b5-1 plan provides for the exercise of fully vested stock o…

  2. F2

    The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $142.00 to $147.29. Upon request by the staff of the U.S.…

  3. F3

    The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $144.49 to $151.27. Upon request by the staff of the SEC,…

  4. F4

    The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $142.51 to $145.19. Upon request by the staff of the SEC,…

Original filing · 0001104659-26-106831
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

PTGX